These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2692427)
1. Potentiation of cell-mediated immune responses directed against P. falciparum sporozoite peptide vaccine by immunomodulators. Russo DM; Sundy JS; Maguire HC; Weidanz WP Adv Exp Med Biol; 1989; 251():203-7. PubMed ID: 2692427 [No Abstract] [Full Text] [Related]
2. Lymphocyte responsiveness to a candidate malaria sporozoite vaccine (R32tet32) of individuals with naturally acquired Plasmodium falciparum malaria. Webster HK; Ho M; Looareesuwan S; Pavanand K; Wattanagoon Y; Warrell DA; Hockmeyer WT Am J Trop Med Hyg; 1988 Jan; 38(1):37-41. PubMed ID: 3277463 [TBL] [Abstract][Full Text] [Related]
3. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax. Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152 [TBL] [Abstract][Full Text] [Related]
4. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. Good MF; Kumar S; Miller LH Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406 [No Abstract] [Full Text] [Related]
5. Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum. Russo DM; Sundy JS; Young JF; Maguire HC; Weidanz WP J Immunol; 1989 Jul; 143(2):655-9. PubMed ID: 2472448 [TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628 [TBL] [Abstract][Full Text] [Related]
8. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. Hui GS; Chang SP; Gibson H; Hashimoto A; Hashiro C; Barr PJ; Kotani S J Immunol; 1991 Dec; 147(11):3935-41. PubMed ID: 1940375 [TBL] [Abstract][Full Text] [Related]
18. The case for a subunit vaccine against malaria. Anders RF Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice. Balam S; Jafarshad A; Servis C; Frank G; Reed S; Pink R; Druilhe P; Spertini F; Corradin G Vaccine; 2016 Mar; 34(13):1566-1574. PubMed ID: 26874325 [TBL] [Abstract][Full Text] [Related]